☆ 4.6 Article

COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes

TRANSPLANTATION (2022)

Related references

Note: Only part of the references are listed.

Article Pharmacology & Pharmacy

The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters

Rana Abdelnabi et al.

Summary: The infectivity of the omicron variant in hamsters was found to be lower than that of the ancestral D614G strain, with a significant decrease in viral RNA load in the lungs and no detectable infectious virus in this organ. Histopathological examination of the lungs from omicron-infected hamsters revealed no signs of peri-bronchial inflammation or bronchopneumonia.

ANTIVIRAL RESEARCH (2022)

Add to Collection

Article Biochemistry & Molecular Biology

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

Wilfredo F. Garcia-Beltran et al.

Summary: Recent surveillance has identified the emergence of the SARS-CoV-2 Omicron variant, which carries up to 36 mutations in the spike protein and has the potential to evade vaccine-induced immunity. This study found that individuals vaccinated with mRNA vaccines exhibited strong neutralization of the Omicron variant, while most vaccinees had weak neutralization. The study also revealed that the Omicron variant infects more efficiently than other tested variants.

CELL (2022)

Add to Collection

Review Infectious Diseases

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

Simon Galmiche et al.

Summary: This article systematically reviews the immunogenicity, efficacy, and effectiveness of COVID-19 vaccines in immunocompromised populations. The results highlight the risk of low immunogenicity in solid organ transplant recipients and patients with hematological malignancy. Enhanced vaccine regimens may be necessary despite the lack of vaccine effectiveness data.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Letter Medicine, General & Internal

Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves

Caroline Maslo et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Letter Medicine, General & Internal

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

Wanwisa Dejnirattisai et al.

LANCET (2022)

Add to Collection

Article Immunology

Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients

Chris J. Callaghan et al.

Summary: The study in England found that vaccination of SOT recipients against SARS-CoV-2 can reduce infection-related mortality, with better outcomes seen in recipients of the ChAdOx1-S vaccine. However, overall protection remains inferior to that in the general population.

TRANSPLANTATION (2022)

Add to Collection

Article Medicine, General & Internal

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients A Randomized Clinical Trial

Roman Reindl-Schwaighofer et al.

Summary: Less than 50% of kidney transplant recipients developed antibodies against the SARS-CoV-2 spike protein after 2 doses of an mRNA vaccine. A third dose of either mRNA or vector vaccine increased antibody response in 39% of KTRs without prior immune response, but neutralizing antibodies and T-cell response remained low. Triple immunosuppression, longer time after transplant, and torque teno virus plasma levels were associated with vaccine response. Local pain was higher with mRNA vaccine, but systemic symptoms were similar between groups.

JAMA INTERNAL MEDICINE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022

Matthew E Modes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Add to Collection

Article Surgery

Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine

Deepali Kumar et al.

Summary: The Omicron variant of the SARS-CoV-2 virus has become the dominant circulating strain globally, and three doses of mRNA COVID-19 vaccine are recommended for transplant recipients. However, there is limited research on the immunogenicity of mRNA vaccines specifically against the Omicron variant. This study analyzed the neutralization effects of Omicron in transplant recipients who received three doses of mRNA-1273 vaccine, and the results showed poor neutralizing responses against the Omicron variant in these patients.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Letter Medicine, General & Internal

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

Rebecca Rockett et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre

Chukwuma A. Chukwu et al.

Summary: This study evaluated the antibody response to SARS-COV-2 vaccines in 707 kidney transplant recipients and found a poor response after two doses of the vaccine. The use of mycophenolic acid, an immunosuppressive drug used after kidney transplantation, had a negative impact on vaccine response.

PLOS ONE (2022)

Add to Collection

Article Medicine, General & Internal

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring et al.

Summary: mRNA vaccines were highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. Three vaccine doses were required for protection against omicron, while two doses provided protection against delta and alpha variants. Omicron variant showed lower disease severity compared to delta variant but still resulted in morbidity and mortality. Vaccinated patients had lower disease severity than unvaccinated patients for all the variants.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Add to Collection

Article Immunology

Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019

Kerri Basile et al.

Summary: The study found that SARS-CoV-2 culture can serve as a surrogate marker for infectivity, helping to inform de-isolation protocols. The virus was more likely to be isolated from samples collected from inpatients and ICU patients, suggesting higher infectivity in these patient populations.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Salim S. Abdool Karim et al.

LANCET (2021)

Add to Collection

Article Medicine, General & Internal

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Anil Gupta et al.

Summary: In this study, among nonhospitalized patients with symptomatic Covid-19, sotrovimab treatment significantly reduced the risk of disease progression leading to hospitalization or death compared to placebo. Patients receiving sotrovimab also had a lower rate of serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Urology & Nephrology

Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis

Edmund Y. M. Chung et al.

Summary: Several studies have shown that the incidence of COVID-19 is higher in CKD patients receiving dialysis, and the death rate in CKD patients with COVID-19 is higher than in those without COVID-19. The findings suggest that COVID-19 may lead to more severe outcomes in patients with CKD.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Add to Collection

Article Microbiology

SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples

C. Lam et al.

Summary: Genomic surveillance of SARS-CoV-2 is crucial for understanding COVID-19 transmission, viral escape mutants, and variants. The ARTIC v3 protocol has high sensitivity in generating complete genomes at low viral loads, with substantial differences in detecting low-frequency variants among different methods.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients

Saima Aslam et al.

Summary: The study found that COVID-19 vaccination significantly reduced the incidence of symptomatic COVID-19 in solid organ transplant recipients, demonstrating real-world clinical effectiveness.

TRANSPLANT INFECTIOUS DISEASE (2021)

Add to Collection

Article Virology

Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool

Aine O'Toole et al.

Summary: The global virus genomics community has responded unprecedentedly to the SARS-CoV-2 pandemic, leading to significant advances in 'real-time' generation and sharing of genomic data. The development of new analytical methods, such as pangolin, has been necessary to handle the rapid growth in virus genome data production. Pangolin has processed nearly two million virus genomes, aiding in SARS-CoV-2 genomic epidemiology and providing researchers with valuable information about the pandemic's transmission lineages.

VIRUS EVOLUTION (2021)

Add to Collection

Article Microbiology

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Andrew Rambaut et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

Rebecca J. Rockett et al.

NATURE MEDICINE (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.